EMA Using Real World Data To Assess Safety Of COVID-19 Vaccines
Oxford/AstraZeneca Vaccine Renamed Vaxzevria In The EU
Executive Summary
The EMA is investigating possible links between the three COVID-19 vaccines currently being used in Europe and cases of thrombotic events. It is also planning safety studies in targeted populations.